Jess S. Morgan & Co’s Checkpoint Therapeutics CKPT Stock Holding History

Jess S. Morgan & Co’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.97M	Buy	189,469 +75,737	+67%	+$902K	1.71%	27
2022 Q2	$1.17M	Buy	113,732 +4,261	+4%	+$55.8K	1.21%	27
2022 Q1	$1.94M	Sell	109,471 -8,112	-7%	-$174K	1.41%	32
2021 Q4	$3.66M	Buy	117,583 +850	+0.7%	+$28.1K	2.25%	28
2021 Q3	$3.85M	Buy	116,733 +4,155	+4%	+$123K	2.54%	31
2021 Q2	$3.32M	Buy	112,578 +53,008	+89%	+$1.47M	2.18%	33
2021 Q1	$1.87M	Buy	+59,570	New	+$2M	1.31%	37

Other funds holding CKPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jess S. Morgan & Co's CKPT Position: Q3 2022 in Review

Jess S. Morgan & Co increased its Checkpoint Therapeutics (CKPT) stake by 67% in Q3 2022, buying an estimated $902K and bringing the position to 189,469 shares worth $1.97M. The position accounts for 1.71% of the portfolio, ranked #27.

Jess S. Morgan & Co first reported a position in CKPT in Q1 2021 and has held it in 7 quarters since. The position peaked at $3.85M in Q3 2021. 57 funds tracked by Wall St. Rank hold CKPT as of Q3 2022.

Jess S. Morgan & Co held 189,469 shares of Checkpoint Therapeutics worth $1.97M as of Q3 2022.
Jess S. Morgan & Co bought 75,737 Checkpoint Therapeutics shares in Q3 2022, an estimated $902K.
Checkpoint Therapeutics made up 1.71% of Jess S. Morgan & Co's portfolio in Q3 2022, its #27 holding.
Jess S. Morgan & Co first reported a position in Checkpoint Therapeutics in Q1 2021 and has held it in 7 quarters since.
Jess S. Morgan & Co's Checkpoint Therapeutics position peaked at $3.85M in Q3 2021.
57 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2022.

Based on Jess S. Morgan & Co's 13F filing for Q3 2022, filed 21 Oct 2022.